← back to search

Patrı́cia T. Bozza

Universidade Federal de Juiz de Fora · BR
Area of research
Public Health, Environmental and Occupational Health · Biochemistry
Research interest
Research interests include Mosquito-borne diseases and control, Lipid metabolism and biosynthesis, COVID-19 Clinical Research Studies, and Immune Response and Inflammation.
h-index
82
citations
23,247
works
914
NIH funding
primary concept
email

Recent publications

Heme and hemozoin induce platelet cell death through UPR-induced apoptosis and ferroptosis in vivax malaria.
2026cited by 1position: contributordoi
Platelet-neutrophil aggregate formation induces NLRP3 inflammasome activation in vaccine-induced thrombotic thrombocytopenia
Journal of Thrombosis and Haemostasis 2025cited by 6position: contributordoi
IL-1β enhances susceptibility to atrial fibrillation in mice by acting through resident macrophages and promoting caspase-1 expression.
2025cited by 5position: contributordoi
Bosutinib mitigates inflammation in experimental sepsis.
2025cited by 3position: contributordoi
Heme and hemozoin induce platelet cell death through UPR-induced apoptosis and ferroptosis in vivax malaria
Blood Advances 2025cited by 3position: middledoi
Prevention of lipid droplet accumulation by DGAT1 inhibition ameliorates sepsis-induced liver injury and inflammation.
2024cited by 23position: contributordoi
Accumulation of lipid droplets induced by Listeria monocytogenes in macrophages: implications for survival and evasion of innate immunity.
2024cited by 8position: contributordoi
Genetic variants in <i>DBC1</i>, <i>SIRT1</i>, <i>UCP2</i> and <i>ADRB2</i> as potential biomarkers for severe obesity and metabolic complications.
2024cited by 7position: contributordoi
Platelet-neutrophil aggregate formation induces NLRP3 inflammasome activation in vaccine-induced thrombotic thrombocytopenia
Journal of Thrombosis and Haemostasis 2024cited by 6position: lastdoi
Unlocking secrets: lipid metabolism and lipid droplet crucial roles in SARS-CoV-2 infection and the immune response.
2024cited by 1position: contributordoi
Extracellular vesicles from primary human macrophages stimulated with VIP or PACAP mediate anti-SARS-CoV-2 activities in monocytes through NF-κB signaling pathway
Microbes and Infection 2024cited by 1position: contributordoi
Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice.
2024cited by 0position: contributordoi
Microglial NLRP3 Inflammasome Induces Excitatory Synaptic Loss Through IL-1β-Enriched Microvesicle Release: Implications for Sepsis-Associated Encephalopathy.
2023cited by 28position: contributordoi
Inhibition of the SREBP pathway prevents SARS-CoV-2 replication and inflammasome activation.
2023cited by 24position: contributordoi
Acute to post-acute COVID-19 thromboinflammation persistence: Mechanisms and potential consequences.
2023cited by 15position: contributordoi
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation.
2023cited by 12position: contributordoi
TF/PAR2 Signaling Axis Supports the Protumor Effect of Neutrophil Extracellular Traps (NETs) on Human Breast Cancer Cells.
2023cited by 8position: contributordoi
Lipid droplets in Zika neuroinfection: Potential targets for intervention?
2023cited by 1position: contributordoi
The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle.
2022cited by 173position: contributordoi
Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19.
2022cited by 58position: contributordoi
Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture.
2022cited by 49position: contributordoi
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts.
2022cited by 39position: contributordoi
Persisting Platelet Activation and Hyperactivity in COVID-19 Survivors.
2022cited by 35position: contributordoi
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.
2022cited by 32position: contributordoi
Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology.
2022cited by 30position: contributordoi
Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19.
2022cited by 26position: contributordoi
Lipid droplet accumulation occurs early following Salmonella infection and contributes to intracellular bacterial survival and replication.
2022cited by 23position: contributordoi
Platelet-leukocyte interactions in the pathogenesis of viral infections.
2022cited by 21position: contributordoi
VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells.
2022cited by 21position: contributordoi
SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System.
2022cited by 21position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 44 papers (2019–2026)Fernando A. Bozza · Montreal Heart Institute41 papers (2012–2025)Thiago Moreno L. Souza · National Institute of Science and Technology37 papers (2019–2024) · 17 papers (2019–2023)Guy A. Zimmerman · University of Utah14 papers (2012–2025) · 12 papers (2020–2026)Suelen S. Gomes Dias · Fundação Oswaldo Cruz11 papers (2020–2025)Jairo R. Temerozo · Fundação Oswaldo Cruz11 papers (2020–2024)Eugênio D. Hottz · Universidade Federal de Juiz de Fora10 papers (2013–2025)Vinicius Cardoso Soares · Universidade Federal do Rio de Janeiro8 papers (2020–2025) · 8 papers (2021–2024)Carolina Q. Sacramento · National Institute of Science and Technology7 papers (2020–2024)Andrew S. Weyrich · Norwegian Womens Public Health Association7 papers (2013–2020)Hugo C. Castro‐Faria‐Neto · Ludwig-Maximilians-Universität München6 papers (2012–2025)Robert A. Campbell · Anna Needs Neuroblastoma Answers6 papers (2019–2025)Pedro Kurtz · D’Or Institute for Research and Education6 papers (2020–2022)Otávio Augusto Chaves · Fundação Oswaldo Cruz5 papers (2021–2023)Natalia Fintelman-Rodrigues · Fundação Oswaldo Cruz5 papers (2021–2024)Dumith C. Bou-Habib · Faculdades Oswaldo Cruz5 papers (2020–2024)Milene Dias Miranda · Fundação Oswaldo Cruz4 papers (2020–2022)